83 FR 2802 - CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 83, Issue 13 (January 19, 2018)

Page Range		2802-2802
FR Document		2018-00824

In accordance with the Federal Advisory Committee Act, this notice announces that the Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will hold a public meeting.

Federal Register, Volume 83 Issue 13 (Friday, January 19, 2018)

[Federal Register Volume 83, Number 13 (Friday, January 19, 2018)]
[Notices]
[Page 2802]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-00824]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Centers for Disease Control and Prevention 
(CDC)/Health Resources and Services Administration (HRSA) Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will 
hold a public meeting.

DATES: February 22, 2018, 2:00 p.m. to 4:00 p.m. ET.

ADDRESSES: This teleconference meeting will accommodate up to 100 
attendees. Parties may access the teleconference by dialing 888-989-
6421 and using participant code 9874492. Participants should call and 
connect 15-minutes prior to the start of the meeting.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment should contact CDR Holly Berilla, Senior 
Public Health Analyst, Division of Policy and Data (DPD), HIV/AIDS 
Bureau (HAB), HRSA, in one of three ways: (1) Mail a request to CDR 
Holly Berilla, Senior Public Health Analyst, HRSA/HAB/DPD, 5600 Fishers 
Lane, 09N156, Rockville, Maryland 20857; (2) call 301-443-9965; or (3) 
send an email to hberilla@hrsa.gov.

SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment was established under 
Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 
217a], as amended.
    The purpose of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment is to advise the Secretary, 
HHS; the Director, CDC; and the Administrator, HRSA regarding 
objectives, strategies, policies, and priorities for HIV, viral 
hepatitis, and other STDs; prevention and treatment efforts including 
surveillance of HIV infection, AIDS, viral hepatitis, and other STDs, 
and related behaviors; epidemiologic, behavioral, health services, and 
laboratory research on HIV, viral hepatitis, and other STDs; 
identification of policy issues related to HIV/viral hepatitis/STD 
professional eduction, patient healthcare delivery, and prevention 
services; Agency policies about prevention of HIV, viral hepatitis and 
other STDs; treatment, healthcare delivery, and research and training; 
strategic issues influencing the ability of CDC and HRSA to fulfill 
their missions of providing prevention and treatment services; 
programmatic efforts to prevent and treat HIV, viral hepatitis, and 
other STDs; and support to the Agencies in their developoment of 
responses to emerging health needs related to HIV, viral hepatitis, and 
other STDs. Information about the Committee and the meeting agenda is 
available by contacting CDR Holly Berilla at the contact information 
above.
    During the meeting, the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment will discuss workgroup 
reports and updates, information regarding the National Ryan White HIV/
AIDS Program Conference, and Committee business-related items. Agenda 
items are subject to change as priorities dictate.
    Due to the nature and time limitations of the meeting, members of 
the public will not have an opportunity to provide oral comments, 
although written comments may be submitted to CDR Holly Berilla at the 
contact information listed above at least 10 days prior to the meeting. 
Individuals who need special assistance should notify CDR Holly Berilla 
at the contact information listed above at least 10 days prior to the 
meeting.

Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-00824 Filed 1-18-18; 8:45 am]
 BILLING CODE 4165-15-P

2802 Federal Register / Vol. 83, No. 13 / Friday, January 19, 2018 / Notices

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued
Average
Responses
Number of Total burden per Total burden
Regulation citation Form name per
respondents responses response hours
respondent (in hours)

Missing Report Form .......... 29 1 29 .08 3

Total ............................. ............................................. 6,059,761 ........................ 6,059,761 ........................ 326,120

HRSA specifically requests comments contact CDR Holly Berilla, Senior Public regarding the National Ryan White HIV/
on (1) the necessity and utility of the Health Analyst, Division of Policy and AIDS Program Conference, and
proposed information collection for the Data (DPD), HIV/AIDS Bureau (HAB), Committee business-related items.
proper performance of the agency’s HRSA, in one of three ways: (1) Mail a Agenda items are subject to change as
functions, (2) the accuracy of the request to CDR Holly Berilla, Senior priorities dictate.
estimated burden, (3) ways to enhance Public Health Analyst, HRSA/HAB/ Due to the nature and time limitations
the quality, utility, and clarity of the DPD, 5600 Fishers Lane, 09N156, of the meeting, members of the public
information to be collected, and (4) the Rockville, Maryland 20857; (2) call 301– will not have an opportunity to provide
use of automated collection techniques 443–9965; or (3) send an email to oral comments, although written
or other forms of information hberilla@hrsa.gov. comments may be submitted to CDR
technology to minimize the information SUPPLEMENTARY INFORMATION: The CDC/ Holly Berilla at the contact information
collection burden. HRSA Advisory Committee on HIV, listed above at least 10 days prior to the
Viral Hepatitis and STD Prevention and meeting. Individuals who need special
Amy McNulty,
Treatment was established under assistance should notify CDR Holly
Acting Director, Division of the Executive Berilla at the contact information listed
Secretariat. Section 222 of the Public Health Service
(PHS) Act, [42 U.S.C. Section 217a], as above at least 10 days prior to the
[FR Doc. 2018–00825 Filed 1–18–18; 8:45 am] meeting.
amended.
BILLING CODE 4165–15–P
The purpose of the CDC/HRSA Amy McNulty,
Advisory Committee on HIV, Viral Acting Director, Division of the Executive
DEPARTMENT OF HEALTH AND Hepatitis and STD Prevention and Secretariat.
HUMAN SERVICES Treatment is to advise the Secretary, [FR Doc. 2018–00824 Filed 1–18–18; 8:45 am]
HHS; the Director, CDC; and the
BILLING CODE 4165–15–P
Health Resources and Services Administrator, HRSA regarding
Administration objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and DEPARTMENT OF HEALTH AND
CDC/HRSA Advisory Committee on other STDs; prevention and treatment HUMAN SERVICES
HIV, Viral Hepatitis and STD Prevention efforts including surveillance of HIV
and Treatment infection, AIDS, viral hepatitis, and Office of the Secretary
other STDs, and related behaviors;
AGENCY: Health Resources and Service epidemiologic, behavioral, health Statement of Organization, Functions,
Administration (HRSA), Department of services, and laboratory research on and Delegations of Authority
Health and Human Services (HHS). HIV, viral hepatitis, and other STDs;
ACTION: Notice of meeting. AGENCY: Office for Civil Rights, Office of
identification of policy issues related to the Secretary, HHS.
HIV/viral hepatitis/STD professional
SUMMARY: In accordance with the SUMMARY: This notice establishes the
eduction, patient healthcare delivery,
Federal Advisory Committee Act, this Conscience and Religious Freedom
and prevention services; Agency
notice announces that the Centers for Division in the Office for Civil Rights of
policies about prevention of HIV, viral
Disease Control and Prevention (CDC)/ the Department of Health and Human
hepatitis and other STDs; treatment,
Health Resources and Services Services.
healthcare delivery, and research and
Administration (HRSA) Advisory SUPPLEMENTARY INFORMATION: In
training; strategic issues influencing the
Committee on HIV, Viral Hepatitis and accordance with Executive Order 13798
ability of CDC and HRSA to fulfill their
STD Prevention and Treatment will Promoting Free Speech and Religious
missions of providing prevention and
hold a public meeting. Liberty (May 4, 2017), 82 FR 21675, and
treatment services; programmatic efforts
DATES: February 22, 2018, 2:00 p.m. to the Attorney General’s Guidance on
to prevent and treat HIV, viral hepatitis,
4:00 p.m. ET. and other STDs; and support to the Federal Law Protections for Religious
ADDRESSES: This teleconference meeting Agencies in their developoment of Liberty (October 6, 2017), Part A, Office
will accommodate up to 100 attendees. responses to emerging health needs of the Secretary, Statement of
Parties may access the teleconference by related to HIV, viral hepatitis, and other Organization, Functions, and
dialing 888–989–6421 and using STDs. Information about the Committee Delegations of Authority for the
participant code 9874492. Participants and the meeting agenda is available by Department of Health and Human
daltland on DSKBBV9HB2PROD with NOTICES

should call and connect 15-minutes contacting CDR Holly Berilla at the Services (HHS), as last amended at 81
prior to the start of the meeting. contact information above. FR 95622 (December 28, 2016), is being
FOR FURTHER INFORMATION CONTACT: During the meeting, the CDC/HRSA amended at Chapter AT, Office for Civil
Anyone requesting information Advisory Committee on HIV, Viral Rights (OCR) to reflect the restructuring
regarding the CDC/HRSA Advisory Hepatitis and STD Prevention and of OCR as follows:
Committee on HIV, Viral Hepatitis and Treatment will discuss workgroup I. Under Chapter AT, Office for Civil
STD Prevention and Treatment should reports and updates, information Rights (OCR), in the outline section

VerDate Sep<11>2014 17:05 Jan 18, 2018 Jkt 244001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\19JAN1.SGM 19JAN1

Document Created: 2018-01-19 02:42:55
Document Modified: 2018-01-19 02:42:55

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meeting.
Dates		February 22, 2018, 2:00 p.m. to 4:00 p.m. ET.
Contact		Anyone requesting information regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment should contact CDR Holly Berilla, Senior Public Health Analyst, Division of Policy and Data (DPD), HIV/AIDS Bureau (HAB), HRSA, in one of three ways: (1) Mail a request to CDR Holly Berilla, Senior Public Health Analyst, HRSA/HAB/DPD, 5600 Fishers Lane, 09N156, Rockville, Maryland 20857; (2) call 301-443-9965; or (3) send an email to [email protected]
FR Citation		83 FR 2802

83 FR 2802 - CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment

DEPARTMENT OF HEALTH AND HUMAN SERVICESHealth Resources and Services Administration

Federal Register Volume 83, Issue 13 (January 19, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration